Cornell's Office of Academic Integration has announced 15 new multi-investigator seed grants, including support for a project on climate change, pollen and asthma attacks and another to develop a microbial delivery system for a unique treatment of colorectal cancer.
By mapping all the protein interactions of a dementia-linked protein in the brain called Tau, a team of Weill Cornell Medicine investigators has created a road map for identifying potential new treatment targets for Alzheimer’s disease and related dementia.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
A study also revealed that expanded duties, particularly emotional care, resulted in a higher perceived value of the workers’ contributions, which could help boost pay for home care workers.
An interdisciplinary seminar in the fall semester took students from Ithaca to New York City to explore African American heritage sites and the people whose work keeps this history alive.
Professors Neil Lewis Jr. ’13 and Tashara Leak are leading the new Action Research Collaborative, which will serve as an institutional hub for cross-campus action research collaborations between Ithaca and New York City, and elsewhere.
While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.
COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine.
Aggressive and relatively common lymphomas called diffuse large B cell lymphomas have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from Cornell researchers.
